PPA
SURF

Parametric Portfolio Associates’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Parametric Portfolio Associates’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$52K Buy
17,715
+7,605
+75% +$26.7K ﹤0.01% 3627
2021
Q4 		$48K Sell
10,110
-2,508
-20% -$16.2K ﹤0.01% 3600
2021
Q3 		$96K Buy
+12,618
New +$80.7K ﹤0.01% 3539
2020
Q4 		– Sell
-235,959
Closed -$1.63M – 4044
2020
Q3 		$1.63M Buy
+235,959
New +$1.43M ﹤0.01% 2636

Other funds holding SURF

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Parametric Portfolio Associates's SURF Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Surface Oncology, Inc. Common Stock (SURF) stake by 75% in Q1 2022, buying an estimated $26.7K and bringing the position to 17,715 shares worth $52K. The position accounts for ﹤0.01% of the portfolio, ranked #3627.

Parametric Portfolio Associates first reported a position in SURF in Q3 2020 and has held it in 4 quarters since. The position peaked at $1.63M in Q3 2020. 103 funds tracked by Wall St. Rank hold SURF as of Q1 2022.

  • Parametric Portfolio Associates held 17,715 shares of Surface Oncology, Inc. Common Stock worth $52K as of Q1 2022.
  • Parametric Portfolio Associates bought 7,605 Surface Oncology, Inc. Common Stock shares in Q1 2022, an estimated $26.7K.
  • Surface Oncology, Inc. Common Stock made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3627 holding.
  • Parametric Portfolio Associates first reported a position in Surface Oncology, Inc. Common Stock in Q3 2020 and has held it in 4 quarters since.
  • Parametric Portfolio Associates's Surface Oncology, Inc. Common Stock position peaked at $1.63M in Q3 2020.
  • 103 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.